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Reninoma (juxtaglomerular cell tumor) is a rare cause of renin-mediated hypertension.
Reninomas are usually diagnosed in adolescents and young adults with occasional reports
in younger children. Patients typically present with a long history of headaches leading
to a diagnosis of severe hypertension that responds well to antihypertensive treatment
targeting the renin-angiotensin-aldosterone system. The clue to clinical diagnosis is the
presence of hypokalemia and metabolic alkalosis on the first blood sample drawn before
any treatment is instituted. Elevated blood levels of renin and aldosterone confirm the
clinical suspicion of renin-mediated hypertension. Diagnostic imaging is employed to iden-
tify the source of excessive renin production. While renal ultrasound can miss reninoma,
contrast CT or magnetic resonance imaging of the kidneys are diagnostic modalities of
choice leading to the correct diagnosis. Renal vein renin sampling with lateralization might
help to identify the site of excessive renin production. Nephron-sparing surgery is curative
with maintenance of normal blood pressure after discontinuation of antihypertensive med-
ications in the majority of patients. In this paper, we present the case of reninoma in an
adolescent girl emphasizing clinical presentation, diagnostic evaluation, and medical and
surgical treatment of this rare tumor. We also discuss important points in the management
of children presenting with renin-mediated hypertension.
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INTRODUCTION
Prevalence of hypertension in children is about 2.5–3%, with some
studies suggesting an increasing trend, making elevated blood
pressure one of the most common conditions in childhood (1).
Severe hypertension (usually defined as blood pressure at least
20 mmHg above the 95% percentile for age, sex, and height)
requires immediate medical attention with gradual reduction of
blood pressure and thorough investigations for the secondary
causes of hypertension (2).
Kidney disease is the most common cause of secondary hyper-
tension – one of the reasons why pediatric nephrologists are usu-
ally involved in the management of these children. Increased pro-
duction of renin from the affected kidneys causes blood pressure
elevation, leading to the development of renin-mediated hyper-
tension. Renovascular disease [renal artery stenosis (RAS)], renal
parenchymal disease (renal dysplasia, scarring, glomerulonephri-
tis), or renin-secreting tumors (Wilms’ tumor, reninoma) are the
most common diagnoses. Reninomas are an uncommon but well-
described cause of renin-mediated hypertension with about 100
reported cases to date (3).
Reninomas are benign tumors originating from the cells of the
juxtaglomerular apparatus. They produce excessive amounts of
renin, leading to secondary hyperaldosteronism. As a consequence
of this hormonal activation, patients develop severe hypertension,
potassium wasting, and hypokalemia.
Due to the non-specific nature of presenting symptoms
(headaches and lethargy being the most common), there is usually
a delay in diagnosis of hypertension, sometimes by years. Even
when hypertension is diagnosed, the identification of reninoma
can be challenging. Medical imaging looking for more common
causes of renin-mediated hypertension, such as renovascular or
renal parenchymal disease, might miss these small tumors. Con-
trast imaging studies and selective venous renin sampling might
be helpful in identifying the source of excessive renin production.
Once correctly diagnosed, reninomas are cured by surgical resec-
tion with the majority of the patients becoming and remaining
normotensive.
In this paper, we describe the case of reninoma in an adolescent
girl, who presented with a long history of headaches suggestive of
renin-mediated hypertension. We present our approach to diag-
nostic evaluation of this patient that led us to the correct diagnosis
of reninoma, and discuss the medical management and surgical
treatment of this rare tumor.
CASE PRESENTATION
A 13-year-old girl was referred to our hospital for treatment
and investigations of hypertension. Eighteen months prior to her
presentation, she developed headaches that slowly increased in
frequency and intensity, eventually occurring daily at the time of
presentation. Her other symptoms and signs included a 2-month
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history of lethargy and intermittent polydipsia and polyuria. There
was no history of nausea, vomiting, syncope, or visual disturbance.
Blood pressure measurement done by her primary care provider
was 200/120.
The patient was in good physical health with the only past
medical complaint of infrequent episodes of asthma. Her only
medication was over-the-counter analgesia for headaches. The
family history was significant for factor V Leiden deficiency in her
father and migraines in her mother and two sisters. There were no
family members diagnosed with hypertension or cardiovascular
disease.
Physical examination on admission to hospital revealed a well-
grown teenage girl. Hypertension was confirmed by blood pressure
readings of 180/120 in both arms and similar readings in the
legs. Pulses were well palpable in all limbs with no radio-femoral
delay. Examination of the heart revealed normal heart sounds and
no murmurs. There was no organomegaly or masses palpable
in the abdomen. Examination of the neck revealed no bruit or
thyroid gland enlargement. Fundoscopy was normal without any
evidence of hypertensive changes. Neurological examination was
normal.
Hypertensive target organ damage evaluation revealed normal
magnetic resonance imaging (MRI) of the brain and structurally
normal heart. There was normal systolic function and trivial aortic
regurgitation by echocardiogram, likely due to the hypertension.
Detailed ophthalmologic examination did not reveal any hyper-
tensive changes. As previously mentioned, kidney function was
normal and there was no proteinuria or hematuria present.
Basic laboratory investigations showed normal urinalysis with
no blood or protein, and normal renal (creatinine 42µmol/L) and
liver function. The biochemical profile on the first blood sam-
ple after admission was normal, apart from mild hypokalemia
(3.0 mmol/L), mild metabolic alkalosis with pH 7.44, and mildly
elevated serum bicarbonate (28 mmol/L). Twenty-four-hour urine
collection revealed normal sodium (102 mmol) and potassium
(53 mmol) excretion in 1.7 L of urine. Because of the association of
long-standing severe hypertension and hypokalemia, our further
work-up focused on the causes of renin-mediated hypertension.
Hormonal studies showed normal plasma and urinary cat-
echolamine and cortisol levels, and normal thyroid function.
Plasma renin (mass) and aldosterone levels were markedly elevated
[1380 mU/L (normal range 3–40 U/L) and 1940 pmol/L (normal
range 100–900 pmol/L), respectively].
Further imaging studies were aimed at localizing the source
of increased renin production. Abdominal ultrasonography did
not reveal any abdominal masses and showed two structurally
normal kidneys, with normal renal blood flows (demonstrated
by Doppler studies). Computed tomographic angiography (CTA)
excluded RAS, but revealed a rounded 10 mm diameter subcapsu-
lar mass under the surface of the anterior midpole of the left kidney
(Figure 1), suggestive of reninoma. To confirm excessive produc-
tion of renin from this tumor, renal vein renin sampling with
lateralization was performed. The procedure was done under gen-
eral anesthetic and ultrasonographic guidance. 4Fr catheters were
inserted into the proximal vein orifices of the left and right renal
vein and sampling for plasma renin mass was undertaken. Plasma
renin sample from the left renal vein was significantly higher
FIGURE 1 | CT angiogram. A sagittal reformat through the left kidney
shows a rounded 10 mm low-attenuation lesion projecting from the
extreme periphery of the anterior renal margin, appearing subcapsular in
position (arrow).
FIGURE 2 | Renal vein renin sampling with lateralization.
Demonstration of the differential hormone levels between the main renal
veins and elevation above systemic hormone levels (all above the upper
limit of normal) confirmed the left kidney tumor as a source of excessive
renin production.
(2900 mU/L) when compared to the right renal vein (840 mU/L)
and the sample from the peripheral vein (908 mU/L), with a L:R
ratio of 3.45:1 (Figure 2).
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The patient remained clinically well during her stay in the hos-
pital. Hypertension was treated with a combination of calcium
channel blocker amlodipine (10 mg/day) and α-blocker prazosin
(2 mg three times per day) with normalization of blood pressure
(120/80) and resolution of headaches. We did not use medications
targeting the renin-angiotensin-aldosterone axis [renin inhibitors,
angiotensin converting enzyme inhibitors (ACEI), angiotensin
receptor blockers, or aldosterone antagonists] to avoid interfer-
ence with renin/aldosterone sampling. Hypokalemia was corrected
with potassium supplementation.
Following the confirmation of the renin-producing tumor in
the left kidney, surgical resection of the tumor was performed. The
patient was placed in the lateral position with left side up. A laparo-
scopic transperitoneal approach, with mobilization and reflection
of the splenic flexure, allowed exposure of the anterior surface of
the left kidney. The vessels were dissected and clamped. The tumor
was removed by sharp dissection (Figure 3A). The parenchymal
defect was closed with interrupted mattress suture and snugged
with a Hem-o-lok (Weck®) to secure hemostasis (Figure 3B). The
specimen was retrieved inside an endocatch bag as to not contami-
nate the abdominal wall. Warm ischemic time of the procedure was
18 min. Blood pressure immediately after the surgery was 100/50.
Prazosin and potassium supplements were subsequently discon-
tinued, and amlodipine was reduced to 5 mg per day with good
control of blood pressure (120/80).
Histological examination of the tumor revealed a well-
circumscribed lesion measuring 15 mm in diameter with cystic
and hemorrhagic changes. The tumor was separated from the
normal kidney parenchyma by an incomplete fibrous capsule
(Figure 4A). The tumor cells were uniform with round nuclei
and eosinophilic granular cytoplasm (Figure 4B). All tumor cells
stained positive for CD34 (Figure 4C) but were negative for
desmin, CD31, S100, HMB-45, synaptophysin, chromogranin,
and WT-1. Constellation of these histological and immunohis-
tochemical features was consistent with the diagnosis of juxta-
glomerular cell tumor (reninoma). The diagnosis was confirmed
by electron microscopy revealing the presence of rhomboid dense
deposits (renin crystals) in the cytoplasm of the tumor cells
(Figure 4D). Cytogenetic examination of the tumor revealed
normal female karyotype 46, XX without any chromosomal
abnormalities.
DISCUSSION
Reninomas (juxtaglomerular cell tumors) are a very rare cause of
renin-mediated hypertension. They originate from the modified
smooth muscle cells of the afferent arteriole of the juxtaglomeru-
lar apparatus (4). Since the first report by Robertson et al. in 1967
(5), approximately 100 cases of reninoma have been published
(3). They are typically diagnosed in adolescents and young adults
with occasional cases reported in younger children (6–9). There
is a mild female to male predominance with a ratio 1.8:1 (7).
Reninomas are benign tumors with only one reported malignant
case (10).
Patients with reninoma usually present with a long history of
symptoms suggestive of severe hypertension, such as headaches,
malaise, or failure to thrive in younger children. Other reported
symptoms are nausea, polyuria with polydipsia, and fatigue (11).
FIGURE 3 | Laparoscopic wedge resection of reninoma. Dissection of
the tumor with scissors (A) and the closure of the defect with interrupted
mattress suture (B).
As symptoms are non-specific, there is often a delay in diagnosis
of hypertension (12).
Our patient presented with long-standing headaches, followed
by the development of lethargy, and polyuria with polydipsia. Her
headaches were initially treated symptomatically due to a posi-
tive family history of migraines. Hypertension was diagnosed only
after several office visits. Blood pressure measurement performed
on presentation, or during subsequent visits to the primary care
provider (perhaps as part of a routine screening assessment) could
have led to a correct diagnosis earlier.
Similar to our patient, many of the reported cases of renino-
mas presented with a long-standing history of headaches with a
significant delays in diagnosis of hypertension (7, 9, 11, 13). The
majority of these patients were children or adolescents.
CLINICAL AND BIOCHEMICAL CONSEQUENCES OF HIGH RENIN
PRODUCTION
Autonomous and persistent secretion of renin by the juxta-
glomerular cells of reninoma leads to the activation of angiotensin
and stimulation of aldosterone secretion by the adrenal glands.
Clinical consequences of this renin-angiotensin-aldosterone sys-
tem (RAAS) activation are peripheral vasoconstriction and salt
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FIGURE 4 | Histopathology of reninoma. (A) Hematoxylin & eosin, ×200
magnification. The arrows point to juxtaglomerular cell tumor (reninoma). An
incomplete fibrous capsule (arrow bases) separates the tumor from normal
kidney (the upper right-hand corner). (B) Hematoxylin & eosin, ×400
magnification. The tumor comprises a uniform population of round to
polyhedral cells with granular, eosinophilic cytoplasm. The growth pattern is
solid with edema and single cells. (C) CD34 immunoperoxidase stain, ×40
magnification. The tumor cells stain positive for CD34. Adjacent glomerular
vasculature acts as an internal positive control. (D) Electron microscopy. The
tumor cells are characterized by uniform non-enlarged nuclei and a cytoplasm
shows numerous pleiomorphic (rounded, polygonal, and rhomboidal) dense
deposits, consistent with renin crystals.
retention leading to systemic hypertension. High aldosterone stim-
ulates sodium–potassium exchange by the principal cells of the
collecting duct leading to excessive potassium loss in urine, deple-
tion of potassium stores in the body, and stimulation of proton
secretion by the intercalated cells of the collecting duct of the
kidney (14), with the development of hypokalemia and meta-
bolic alkalosis. These pathophysiologic changes are not specific
for reninoma and are usually present in all renin-mediated causes
of hypertension. Patients with reninoma, however, tend to be older
than children with renovascular or renal parenchymal disease, and
usually have no or minimal past medical complaints.
Assessment of urinary excretion of electrolytes is useful but
requires 24-h collection of urine. Potassium excretion is com-
monly within normal daily limits; however, this is inappropriately
normal excretion, given the depletion of body potassium stores.
Both, the degree of hypokalemia and the amount of potassium
excreted in urine, are influenced by the dietary intake of potas-
sium. Hence, a review of the patient’s diet by a dietician is help-
ful. Our patient presented with hypokalemia and mild metabolic
alkalosis. A urine electrolyte excretion study confirmed inappro-
priately normal potassium excretion (contrary to what we would
expect given the low blood level of potassium), suggestive of
hyperaldosteronism.
In hypertensive patients presenting with hypokalemia (and
sometimes metabolic alkalosis), high aldosterone is the likely
cause, guiding the investigations toward renal or adrenal causes
of hypertension. Ideally, the measurement of plasma and urine
electrolytes is done before any treatment (including intravenous
fluid administration) is instituted.
In cases of suspected renin-mediated hypertension, the most
physiological choice of antihypertensive treatment is the block-
ade of RAAS (15). This can be done at multiple levels of the axis
by using renin inhibitors (aliskiren), ACEI, angiotensin II recep-
tor blockers (ARB), or aldosterone antagonists (spironolactone,
eplerenone). Traditionally, ACEIs and ARBs have been most com-
monly used in clinical practice. It is important to remember that
these medications affect the production and secretion of RAAS
hormones and thus alter the blood levels of these hormones. For
that reason, we treated our patient’s hypertension with a combina-
tion of calcium channel blocker (amlodipine) and α-blocker (pra-
zosin), which allowed us to sample renin and aldosterone without
interference. We achieved good blood pressure control with this
combination of antihypertensives, and therefore continued with
this treatment until the surgical removal of reninoma.
HORMONAL STUDIES FOR RENIN-MEDIATED HYPERTENSION
The next step in diagnostic evaluation of hypertensive patients
presenting with hypokalemia and metabolic alkalosis is the mea-
surement of renin and aldosterone blood levels to confirm renin-
mediated hypertension. High renin and high aldosterone com-
bined with a normal renin/aldosterone ratio are suggestive of
normal, albeit excessive, secretion of both hormones typical of
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the renal causes of hypertension (RAS, renal parenchymal disease,
or reninoma). A high aldosterone level with a suppressed level
of renin point to the adrenal cause (tumor, hyperplasia), where
abnormal autonomous hypersecretion of aldosterone suppresses
the secretion of renin by the kidneys. The production of renin
and aldosterone can be influenced by many factors, including the
state of hydration, dietary intake of salts, postural changes, and
medications (16). The levels of these hormones can also fluctuate
with time, but the elevation above the upper range limit is usually
sustained.
We routinely perform three measurements of renin and aldos-
terone blood levels while avoiding medications targeting RAAS.
In our case, both renin and aldosterone blood levels were signifi-
cantly elevated, with a normal renin/aldosterone ratio confirming
the appropriate activation of RAAS, suggestive of renal cause of
hypertension.
IMAGING OF RENIN-MEDIATED HYPERTENSION
As a particularly rare cause of hypertension, reninoma is sel-
dom strongly considered in the imaging work-up in cases of
pediatric hypertension. As characteristically small lesions at pre-
sentation (≤10 mm), reninomas are easily overlooked at imag-
ing – imaging typically directed at identifying a vascular cause for
renin-mediated hypertension (17).
Plain radiographs are of limited diagnostic value. Occasionally,
secondary signs of hypertension such as cardiomegaly and aor-
tic unfolding or cardiogenic or “flash” pulmonary edema will be
evident on chest radiography.
The Doppler interrogation of the renal vasculature dominates
the ultrasound (US) investigation of hypertension, which detracts
from a detailed B-mode evaluation of the kidney substance –
whether in search of renal scarring or tumor. Further compounded
by a child’s limited tolerance of protracted examinations, in prac-
tice US is not a reliable means of evaluating for vascular or
neoplastic causes of pediatric hypertension.
Computed tomographic angiography is generally considered
the mainstay technique in the imaging evaluation of renin-
mediated hypertension in children. Though significant, the radi-
ation burden associated with CT is justified through a number
of advantages over other modalities. When compared to MRI,
CT is readily accessed and performed, possesses superior spatial
and temporal resolution, is well tolerated amongst children, and,
notably, is the favored modality amongst interventionalists and
surgeons when planning procedures. For patients with diminished
renal function when the nephrotoxic effects of iodinated contrast
may be amplified, as with gadolinium-based contrast for MRI, spe-
cific measures such as pre-hydration may be necessary. CTA has
been reported to have 100% sensitivity in diagnosing even small
reninomas (11).
Formal renal angiography, though not specifically indicated
in cases of reninoma, is often performed in cases of suspected
RAS and in cases likely requiring radiological intervention such as
balloon angioplasty or pre-operative tumor embolization.
In this case, renal US missed the diagnosis of reninoma. Because
of the normal appearance of the kidneys, we suspected a reno-
vascular cause of hypertension. CTA excluded RAS but revealed
the small subcapsular tumor (reninoma) of the left kidney as a
suspected cause of hypertension. This tumor would also likely
have been missed on MRI because of its small size. Conven-
tional angiography, which was briefly contemplated for the patient,
would have also missed the tumor (18).
As an excellent means of imaging of the renal vasculature, renal
parenchyma, and adrenal glands, we recommended that CTA be
considered in all cases of renin-mediated hypertension in children.
SELECTIVE RENAL VEIN RENIN SAMPLING WITH LATERALIZATION
Renin sampling from both renal veins (lateralization) and the
peripheral vein helps to localize the site of renin production (4, 13).
It has been suggested that renin lateralization ratio (LRR)> 1.5
maximizes the specificity of this investigation (11). Our patient’s
LRR was 3.45 favoring the left kidney, confirming that the lesion
seen on CT was producing excessive quantity of renin. Following
this confirmation, the risks of surgical resection could be justified.
SURGERY FOR RENINOMA
Surgical resection of reninoma is curative and restores normal
blood pressure in the majority of patients. Occasional cases of per-
sistent hypertension following reninoma resection are thought to
be either due to other causes of hypertension, or to cardiovascular
changes from long-standing hypertension (12, 19, 20). Whether
these patients eventually become normotensive is difficult to
predict given no reports on long-term follow-up.
In designing the optimal approach for our patient and her
renin-secreting tumor, we appreciated the likely benign nature of
this lesion (20). To preserve as much normal functional nephron
mass as possible, nephron-sparing surgery in the form of partial
nephrectomy, wedge excision, or even tumor enucleation are all
possible alternatives to complete nephrectomy for reninomas.
The surgical procedure is done either by open or, more
commonly, laparoscopic approach (21). Minimal access surgery
ensures better magnification, improved postoperative recovery
profile, and better cosmetic results compared to traditional open
renal surgery. Complete resection of reninoma with an adequate
rim of normal kidney tissue (at least 0.5 cm) is important (22).
Warm ischemic times are usually less than 30 min with no cases of
acute kidney injury reported in the literature. The surgery is well
tolerated and most patients are discharged home within a few days
after surgery.
Although both retroperitoneal and transperitoneal minimal
access routes have been described (22, 23), we adopted the
transperitoneal route in our patient because of a large experience
with transperitoneal partial nephrectomy for adult renal tumors
in our department. This allowed us to perform a complete, safe,
and successful wide excision, within tolerable warm ischemia time
of< 30 min.
HISTOPATHOLOGY OF RENINOMA
Histological examination of the excised tumor is essential for con-
firming the diagnosis of reninoma because other renal tumors
can also secrete renin (24). The correct diagnosis is based on
the combination of macroscopic appearance of the tumor, light
microscopy of the tumor cells, immunohistochemical staining for
various cell markers (including renin), and typical ultrastructural
finding of intracellular renin deposits (3, 8).
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Reninomas are usually small subcapsular tumors, well circum-
scribed, and mostly encapsulated. Macroscopically, the surface of
the tumor is pale or purple with occasional cystic or hemorrhagic
areas.
On light microscopy, reninomas are composed of closely
packed uniform, round to polyhedral cells with granular,
eosinophilic cytoplasm. The nuclei are round to oval with few
mitoses. Prominent thick and thin-walled vessels are usually
present.
The diagnosis of reninoma is usually confirmed by cytoplas-
mic positivity for renin. Renin positivity may also be observed
in some cases of Wilms’ tumor (WT-1 staining), renal cell car-
cinoma (RCC), or renal oncocytoma. Most neoplastic cells are
also diffusely positive for CD34 (a vascular marker), an additional
marker that can differentiate reninoma from RCC (8). Reni-
nomas are negative for S100 protein, HMB-45 (melanoma and
angiomyolipoma markers), chromogranin, synaptophysin (neu-
roendocrine markers), and cytokeratin (a pan-epithelial marker
more specific for RCC).
Ultrastructurally, the cells feature rhomboid, renin-specific
crystals, similar to those found in normal juxtaglomerular appa-
ratus.
Our patient’s tumor consisted of a uniform population of
round to polyhedral cells, with granular, eosinophilic cytoplasm
suggestive of juxtaglomerular cells. Immunoperoxidase staining
for renin was not available. All tumor cells stained strongly for
CD34. Staining for other markers, including cytokeratin, was
negative, essentially excluding other kidney tumors. Electron
microscopy revealed renin deposits in the cytoplasm of the tumor
cells, confirming the diagnosis of reninoma.
Chromosomal abnormalities have been reported in cases of
reninoma, with monosomy of chromosome 9, 11, and 15, and
polysomy of chromosomes 3, 4, 10 13, 17, and 18 (3). The causative
gene(s) are, however, unknown at present. Some studies suggest
that the possible oncogene(s) or tumor suppressor gene(s) may
be localized on chromosome 4 and 10, or chromosome 9 and
11, respectively (3, 25, 26). No chromosomal abnormalities were
detected in our patient.
CONCLUDING REMARKS
Reninomas are a rare but curable cause of secondary hyper-
tension. The diagnosis of reninoma should be considered in
patients presenting with severe hypertension, hyperreninemia,
hyperaldosteronism, and hypokalemia in whom renovascular and
renal parenchymal disease have been excluded. Enhanced imaging
modalities and invasive renin sampling are helpful diagnostic tests
leading to the correct diagnosis. Antihypertensive treatment with
medications targeting RAAS is effective, but can affect the levels
of renin and aldosterone if instituted before the collection of the
samples for measurement of these hormones. Surgical resection
of reninoma (nephron-sparing surgery) is the treatment of choice
and leads to normalization of blood pressure.
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